Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$72.1M Buy
2,613,414
+7,755
+0.3% +$171K 0.01% 991
2026
Q1
$38.1M Buy
2,605,659
+184,460
+8% +$2.71M 0.01% 1337
2025
Q4
$30.6M Buy
2,421,199
+100,468
+4% +$1.48M ﹤0.01% 1481
2025
Q3
$35.7M Buy
2,320,731
+226,832
+11% +$3.66M 0.01% 1368
2025
Q2
$32.9M Buy
2,093,899
+479
+0% +$7.26K 0.01% 1367
2025
Q1
$40M Sell
2,093,420
-51,613
-2% -$1.13M 0.01% 1216
2024
Q4
$51.1M Buy
2,145,033
+76,653
+4% +$2.14M 0.01% 1117
2024
Q3
$57.9M Buy
2,068,380
+136,886
+7% +$3.87M 0.01% 1024
2024
Q2
$50.5M Buy
1,931,494
+69,552
+4% +$1.45M 0.01% 1070
2024
Q1
$40.7M Buy
1,861,942
+38,423
+2% +$823K 0.01% 1166
2023
Q4
$42.4M Buy
1,823,519
+141,056
+8% +$2.84M 0.01% 1105
2023
Q3
$33.2M Buy
1,682,463
+112,970
+7% +$2.22M 0.01% 1166
2023
Q2
$35.6M Buy
1,569,493
+319,670
+26% +$6.44M 0.01% 1107
2023
Q1
$24.5M Buy
1,249,823
+529,926
+74% +$10.2M 0.01% 1309
2022
Q4
$12.4M Buy
+719,897
New +$12.8M ﹤0.01% 1734

Other funds holding RXO

Charles Schwab's RXO Position: Q2 2026 in Review

Charles Schwab increased its RXO (RXO) stake by 0.3% in Q2 2026, buying an estimated $171K and bringing the position to 2,613,414 shares worth $72.1M. The position accounts for 0.01% of the portfolio, ranked #991.

Charles Schwab first reported a position in RXO in Q4 2022 and has held it in 15 quarters since. 303 funds tracked by Wall St. Rank hold RXO as of Q2 2026.

  • Charles Schwab held 2,613,414 shares of RXO worth $72.1M as of Q2 2026.
  • Charles Schwab bought 7,755 RXO shares in Q2 2026, an estimated $171K.
  • RXO made up 0.01% of Charles Schwab's portfolio in Q2 2026, its #991 holding.
  • Charles Schwab first reported a position in RXO in Q4 2022 and has held it in 15 quarters since.
  • 303 funds tracked by Wall St. Rank held RXO as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.